05/15/12 Quality of Life Improves with Early Detection and Management of COPD
Washington, DC--The COPD Foundation announced today that expanding the awareness and education of the management of Chronic Obstructive Pulmonary Disease including early screening, diagnosis, and management, remains critical to efforts to combat this disease and improve the quality of life in COPD patients.
"The complications arising from recently published results of a Veterans Affairs study of patients with advanced, severe disease further illustrate the importance of early detection and m
Read More »
05/03/12 May is Asthma Awareness Month
May is Asthma Awareness Month, a time for Americans to learn more about this chronic respiratory disease, which, according to the U.S. Environmental Protection Agency, negatively impacts quality of life for more than 24 million Americans, including more than seven million children.
Asthma is a serious, sometimes life-threatening health issue that can be triggered by environmental irritants such as smog, smoke and chemicals, as well as contact with substances that generate allergies, including
Read More »
04/16/12 Dr. Philip Marcus, Member of the COPD Foundation's Clinical Advisory Committee, Dies
The COPD Foundation and our community are saddened to share with you the unfortunate news that Dr. Philip Marcus, MD, MPH, FCCP, member of our recently constituted COPD Foundation Clinical Advisory Committee (CAC) died suddenly last weekend while on a family vacation in France.
Prominent, well liked, honored, and respected throughout New York State and beyond he was recently recognized by the ALANY with the Life & Breath Award. Philip Marcus was the founding physician of Nassau Chest Physic
Read More »
04/05/12 Cardiologist Gibbons of Morehouse School of Medicine named to head NHLBI
WASHINGTON — National Institutes of Health Director Francis S. Collins MD, PhD, announced today the selection of Gary H. Gibbons, MD, as the new director of the NIH’s National Heart, Lung, and Blood Institute (NHLBI). Gibbons is the founder and current director of the Cardiovascular Research Institute, chair of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine in Atlanta.
Gibbons’ institute at Morehouse is recognized f
Read More »
03/28/12 DRIVE4COPD to be Led by COPD Foundation
FOR IMMEDIATE RELEASE
DRIVE4COPD, Country’s Largest Public Health Initiative Dedicated to Raising Awareness of Chronic Obstructive Pulmonary Disease (COPD),
to be led by COPD Foundation
WASHINGTON, D.C. – March 28, 2012 – The successful national campaign to increase public awareness of COPD changed organizational leadership effective March 23, 2012. Led since inception by Boehringer Ingelheim Pharmaceuticals Inc., a leader in developing medicines to treat COPD,
Read More »
03/26/12 Toolkit Helps RTs with Rehab Information
Obtaining a permanent Pulmonary Rehabilitation benefit for Medicare beneficiaries is an important victory for the U.S. COPD Coalition. Yet reimbursement for this benefit by Medicare is not enough to sustain many Pulmonary Rehabilitation programs. The Medicare data reveals that much of the problem with reimbursement is due to improper billing of the benefit by Pulmonary Rehabilitation centers.
In an effort to combat this problem and help the provider community, the American Association
Read More »
03/26/12 COPD Foundation Achieves Significant Milestones with C.O.P.D. Information Line
WASHINGTON--The COPD Foundation (COPDF) today announced that its toll-free, HIPAA-compliant Call Our Patients Direct (C.O.P.D.) Information Line has achieved significant milestones, reaching 30,000 individuals in 2011, communicating in 175+ languages including English, Spanish, French and Italian, and providing one-on-one assistance to individuals with COPD, their family members and caregivers. Operated by a team of professional, highly trained, peer-to-peer patients and caregivers, the contact
Read More »
01/31/12 Little-known disease pushes life to the edge
Karen Erickson was told she had two years to live 11 years ago.
The 45-year-old Thousand Oaks woman with lungs that work at less than 20 percent was diagnosed with a disease so little-known that the physician's assistant who delivered the news didn't get it quite right.
"She said: 'You have alpha-1 antitrypsin deficiency. Your body is eating your own lungs,' " Erickson said. "She said, 'There's no cure, but if we get you on treatment, we think we could get you a couple more years.' ... I t
Read More »
01/13/12 Help Increase Access to Respiratory Therapists!
Last year respiratory therapists and COPD and Alpha-1 patients headed to Washington where they met with elected officials and urged them to support the Medicare Respiratory Therapy Initiatve.
When Medicare was created 40 years ago, very few respiratory therapy services were provided outside of the hospital. However, times and respiratory medicine has significantly changed, but Medicare, at least in terms of respiratory therapy has not.
Now, there are important services such as smoking cess
Read More »
01/09/12 COPD Foundation Hires New Executive Director
Media Contact:
Ervin Torres
CPR Communications
etorres@cpronline.com
201-641-1911 x22
FOR IMMEDIATE RELEASE
COPD Foundation Hires New Executive Director
Dave Barringer to lead development, fundraising and marketing initiatives
WASHINGTON, DC – January 9, 2012 – The COPD Foundation (COPDF) today announced the appointment of Dave Barringer, former senior vice president of Member Relations for Goodwill Industries International, as COPDF’s new executive directo
Read More »
11/04/11 COPD Foundation Leads Campaign During November COPD Awareness Month
November: Chronic Obstructive Pulmonary Disease (COPD) Awareness Month World COPD Day November 16, 2011
Washington, D.C. – November 4, 2011 – On behalf of the 24 million Americans living with Chronic Obstructive Pulmonary Disease (COPD), the third leading cause of death in the U.S. and a disease that kills one person every four minutes, the COPD Foundation is leading the call for increased research initiatives, enhanced screening and diagnosis, improved treatment and therapies, an
Read More »
11/03/11 COPD Rises to Third Leading Cause of Death in the United States, 12 Years Earlier Than Projected
Reprinted from Managed Care Outlook, November 1, 2011, Volume 24, Number 21, pages 1,7–9 with permission from Aspen Publishers, Wolters Kluwer Law & Business.
The Centers for Disease Control and Prevention’s (CDC’s) National Center for Health Statistics (NCHS) recently released a report titled “Deaths: Preliminary Data for 2008” in which it confirms that chronic obstructive pulmonary disease (COPD) became the third leading cause of death in the United States
Read More »
10/31/11 An Alpha-1 COPD Love Story: A "Must Read"
Sally Everett writes about her life with Alpha-1 lung disease — and with her husband, Gordon Snider, MD
By SALLY EVERETT
First printed in Alpha-1-To-One magazine
It was January 1993; I was about to turn 50 and seemingly a picture of health. I ate right, I didn’t smoke, I was almost never sick and I exercised regularly. Less than a month later, however, I’d been diagnosed with COPD and Alpha-1, the genetic abnormality that caused it. My doctor said I had, at most, 10 years t
Read More »
10/18/11 COPDF Congratulates Boehringer Ingelheim and Biosector 2 for “Best Use of Social Media" Award
The COPD Foundation is delighted to congratulate Boehringer Ingelheim Pharmaceuticals and Biosector 2 for winning Medical Marketing and Media’s “Best Use of Social Media” Gold Award for the incredible success of DRIVE4COPD.
This award recognizes “excellence from digital initiatives, targeting either consumers/patients or healthcare professionals that use social media channels such as Facebook, Twitter and YouTube.”
As a partner in DRIVE4COPD—the nation
Read More »
10/17/11 COPD Foundation (as part of MAPRx) in Support of Protecting Part D of Medicare
The COPD Foundation and numerous organizations--as part of MAPRx (Medicare Access for Patients Rx)--wrote a letter to Senator Patty Murray and Representative Jeb Hensarling, Co-Chairs of the Joint Select Committee on Deficit, about the importance of protecting Part D of Medicare as it applies to improving access to prescription medications and safeguarding the well-being of beneficiaries with chronic diseases.
Click here to read the letter.
Read More »
10/10/11 FDA Approves Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray
Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler
Ridgefield, CT, Oct. 10, 2011 - Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler (C
Read More »
10/06/11 Grace Anne Dorney Koppel Will be Keynote Speaker at AARC Congress 2011
Grace Anne Dorney Koppel will be the keynote speaker at the American Association for Respiratory Care (AARC) Congress 2011, according to their website.
Her keynote address is titled, "Dispensing Courage" and it will focus on the real meaning of heroism and courage in the context of working with COPD patients for whom there is no medical cure.
Koppel will share her insights into COPD and pulmonary rehabilitation with Congress goers during the opening ceremonies in Tampa on Nov. 5, and atten
Read More »
10/04/11 COPDF President John Walsh Presents at COPD Symposium in Beijing, China
COPD Foundation President and Co-Founder, John W. Walsh, was able to bring the discussion of COPD to the global scale this past September, when he was invited to give a presentation at the international COPD Symposium held in Beijing by the Chinese government, China. His talk focused on “COPD Patients: Hope, Fears and Expectations.”
The purpose of the meeting was to share information and discuss topics related to COPD, Globally and in China, including: the burden of illness in CO
Read More »
09/29/11 The DRIVE4COPD Campaign Screens 2 Million People!
Today, the DRIVE4COPD campaign announced they have reached the impressive milestone of screening 2 million Americans to see if they are at risk for COPD.
Launched in February 2010, DRIVE4COPD is the nation's single largest awareness campaign for chronic obstructive pulmonary disease (COPD).
The COPD Foundation is proud to be a partner of this initiative and want to thank those members who have participated in this effort either by taking the screener or encouraging others to do the same.
Read More »
09/29/11 New Important Safety Information Related to PERFOROMIST®
Dey Pharma, L.P. would like to inform you of important safety-related changes to the PERFOROMIST® (formoterol fumarate) Inhalation Solution, 20 mcg/2mL prescribing information.
PERFOROMIST® is a long-acting beta2-adrenergic agonist (LABA) indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema.
New important
Read More »
09/14/11 24M: The DRIVE4COPD Monument Unveiled in New York City
FOR IMMEDIATE RELEASE
Two-Ton Pinwheel Monument Raises Awareness Of Chronic Obstructive Pulmonary Disease
Ridgefield, CT, September 14, 2011 – Landmark public health campaign DRIVE4COPD today announced the unveiling of 24M: The DRIVE4COPD Monument, a visual representation of the impact of chronic obstructive pulmonary disease (COPD) in the United States. Reaching 14 feet at its highest peak and spanning half a football field, this first-of-its-kind monument comprised of 24 large-scale
Read More »
09/13/11 COPD Foundation Makes Progress on Biomarker Qualification to Speed New Drug Development
The COPD Foundation recently met with Dr. Janet Woodcock, Director of the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), as well as other FDA staff members. The meeting focused on the need to move forward with qualification of biomarkers that could be used to speed development of new therapies for COPD. The COPD Foundation, through its COPD Biomarkers Qualification Consortium (CBQC), has brought together pharmaceutical companies, academic researche
Read More »
09/01/11 CMS Releases Round 2 Product Categories
Centers for Medicare & Medicaid Services (CMS) has issued an update on its "competitive" bidding program including information about Round Two product categories. Details follow.
Round 2 includes the following product categories:
Oxygen Supplies and Equipment
Standard (Power and Manual) Wheelchairs, Scooters, and Related Accessories
Enteral Nutrients, Equipment and Supplies
Continuous Positi
Read More »
08/23/11 President John Walsh Quoted in the Health Section of New York Times Online
COPD Foundation President John Walsh was quoted in the Health Section of the New York Times online on August 19th, 2011.
Read the full article here.
Read More »
08/19/11 CDC citation on COPD (CLRD) as the 3rd leading cause of disease
In a National Center for Health Statistics (NCHS) Data Brief from June 2011, the Centers for Disease Control and Prevention (CDC) sites Chronic Lower Respiratory Disease (CLRD)--which includes both COPD and asthma--to be the third leading cause of death in the United States in 2008.
Also in the report: trends in COPD prevalence, hospitalization, and death rates, and detailed recent estimates for population subgroups.
To read the report, click here.
Read More »
08/17/11 COPD Foundation and New York Mets Host COPD Awareness Night at Citi Field
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Stephanie Clark, CPR Communications
201-641-1911 x53
sclark@cpronline.com
New York Mets
Danielle Parillo
718-565-4354
dparillo@nymets.com
Citi Field, Flushing, NY, August 20, 2011 @ 4:10PM; Mets vs. Brewers Series
Washington, DC/NEW YORK METRO – August 17, 2011 – The COPD Foundation and the New York Mets will host a Chronic Obstructive Pulmonary Disease (COPD) Awareness Night at Citi Field, Saturday, August 2
Read More »
08/09/11 Medicare Provides Assistance; Helps Low-Income Beneficiaries
FOR IMMEDIATE RELEASE
Contact:
CMS Media Relations Group
202) 690-6145
Washington DC, August, 9, 2011 – Some Medicare beneficiaries could qualify for assistance with their prescription drug costs, and be eligible this year to pay no more than $2.50 for generic drugs and $6.30 for each brand name drug. The steps and requirements beneficiaries can take to check if they qualify for the Medicare Low-Income Subsidy Program (also known as LIS or “Extra Help”) are simple and
Read More »
08/08/11 Breathing in America Aims to Increase Public Awareness of Lung Disease
Lung disease is the third-leading killer in the United States and around the world, yet many lung diseases are under-recognized and research is grossly underfunded. However, a new book, Breathing in America: Diseases, Progress, and Hope, produced by the American Thoracic Society, shines a strong light on lung disease and research, exploring the nature and causes of pulmonary, critical care and sleep disorders, their prevalence and burden, the benefits research has brought and the research challe
Read More »
07/11/11 COPD Foundation Commends Congressman Leonard Lance (R-NJ) for Raising Issues Regarding Biomarkers
Contact:
COPD Foundation
Stephanie Clark
201-641-1911 x53
sclark@cpronline.com
FOR IMMEDIATE RELEASE
Washington, D.C. (July 11, 2011)—The COPD Foundation acknowledges the actions of Rep. Leonard Lance (R-NJ) in posing a key question about biomarkers during the discussion on July 7, 2011 by the U.S. House Energy and Commerce Subcommittee on Health about reauthorization of the Prescription Drug User Fee Act (PDUFA), which expires on September 30, 2012. The subcommittee als
Read More »
07/05/11 Novartis Wins FDA OK of Low-Dose COPD Therapy
The US Food and Drug Administration (FDA) has approved a once-daily bronchodilator for chronic obstructive pulmonary disease (COPD) that promises better patient adherence than twice-a-day bronchodilators on the market.
The new drug is indacaterol maleate, which will be marketed by Novartis Pharmaceuticals as the Arcapta Neohaler. It is a long-acting beta2-agonist (LABA).
"With millions of Americans known to be affected by COPD, the approval of Arcapta is good news for patients," says John
Read More »
06/28/11 COPD Foundation, New York Mets Hosting COPD Awareness Night at Citi Field
Contact:
COPD Foundation
Katelyn Harding
866-731-2673, ext. 270
kharding@copdfoundation.org
New York Mets
Danielle Parillo
718-565-4354
dparillo@nymets.com
FOR IMMEDIATE RELEASE
COPD Foundation, New York Mets Hosting
COPD Awareness Night at Citi Field
Citi Field
Flushing, NY
August 20, 2011 @ 4:10PM
Mets vs. Brewers
Washington, DC – June 28, 2011 – The COPD Foundation and the New York Mets will be hosting an Awareness Night at Citi Field for Chr
Read More »
06/23/11 Grifols Has Acquired Talecris Biotherapeutics
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, has completed acquisition of Talecris Biotherapeutics. They will now operate under the company name Grifols.
"The union of our two companies provides an infusion of energy and talent, and strengthens our commitment to our shared mission of providing life-saving therapies to patients with rare, chronic diseases," said Victor Grifols, President and CEO of Grifols. "The strength of our combined co
Read More »
06/22/11 Sen. Dick Durbin Signs On as Co-Chair of COPD Congressional Caucus
Washington, DC – June 22, 2011 – Today, Senator Dick Durbin (D-IL) officially became the Co-Chair of the Congressional COPD Caucus. The Caucus serves as a platform for the community of patients affected by Chronic Obstructive Pulmonary Disease (COPD) to voice their concerns.
“Approximately 24 million Americans—including 557,120 people in Illinois—are living with COPD," says Senator Dick Durbin. "While there is no cure, the causes are largely preventable.&nbs
Read More »
06/17/11 COPD Foundation Supports FDA Improvements
Miriam O’Day and Dr. William Mattes, both of the COPD Foundation, attended a Capitol Hill briefing hosted by the Friends of Cancer Research, which featured, among other panelists, Dr. Janet Woodcock, Director, FDA CDER. (Pictured below, with William Mattes).
The briefing introduced and discussed a recent report that analyzed FDA and EMA (European Medicines Agency) cancer drug approvals and found that, contrary to popular opinion, FDA reviews and approvals were faster than those in Euro
Read More »
06/15/11 CDC Releases Public Health Strategic Framework for COPD Prevention
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
CDC Releases Public Health Strategic Framework for COPD Prevention
WASHINGTON, DC (June 2011)—The Centers for Disease Control and Prevention (CDC) released its Public Health Strategic Framework for COPD Prevention to provide the public health community with a guide on how to address COPD as an important public health issue.
"This is the first such report publish
Read More »
06/14/11 Navarro Pharmacy and COPD Foundation Offering Free Lung Tests at Grand Opening of North Miami Store
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
FOR IMMEDIATE RELEASE
Navarro Pharmacy and COPD Foundation Offering Free Lung Tests at Grand Opening of the North Miami Store
COPD Foundation will be offering the public free testing for Chronic Obstructive Pulmonary Disease for Four Weeks on Wellness Wednesdays
Miami, FL – June 14th, 2011 – The COPD Foundation is collaborating with Navarro Pharmacy—the largest Hispanic pharma
Read More »
06/14/11 CDC Releases Public Health Strategic Framework for COPD Prevention
The Centers for Disease Control and Prevention (CDC) released its Public Health Strategic Framework for COPD Prevention, based on a workshop in the spring of 2010 that many members of the COPD Foundation leadership participated in at the CDC.
"This is the first such report published by the CDC and demonstrates a heightened commitment and awareness of the health burden of COPD, and the importance to initiate prevention programs and data collection," John W. Walsh, president and co-founder of
Read More »
06/13/11 Pre-Existing Condition Insurance Plan (PCIP) Changes
If you know people who are uninsured because of a pre-existing condition, getting health coverage under the Pre-Existing Condition Insurance Plan (PCIP) is now a lot easier and more affordable.
On May 31st, the Department of Health and Human Services announced new eligibility standards and lower premiums in some states that will now make this program, created by the Affordable Care Act, available to many more Americans.
These changes include:
Reduced Premiums:
Prem
Read More »
06/08/11 Collin Scarborough, Foundation Board Member and Friend, Passed Away
It is with sadness and respect that we inform you our fellow board member, Collin Scarborough, passed away this morning at his home in Hilton Head, SC after a battle with cancer and renal failure. Collin was responsible for the creation of the Richard H. Scarborough Bronchiectasis Research Consortium and Registry and his family donated the initial funds to support this important initiative. We will always remember Collin as a very passionate advocate brought on by his brother Richard's deva
Read More »
06/07/11 REAP
Regulatory Education and Action for Patients (REAP) submitted comments today on the “Medicare Shared Savings Program: Accountable Care Organizations”.
REAP is an umbrella coalition comprised of patient advocacy groups whose goal is to strengthen current relationships and build new relationships with government agencies that have the responsibility for implementing provisions of the Patient Protection and Affordable Care Act, as amended, and to ensure that implementation of the Ac
Read More »
06/01/11 Grifols Purchases Talecris Biotherapeutics, Manufacturer of Prolastin-C Augmentation Therapy for A1
The U.S. Federal Trade Commission today approved the Grifols purchase of Talecris Biotherapeutics, the manufacturer of Prolastin-C augmentation therapy for Alpha-1 Antitrypsin Deficiency.
Talecris is the manufacturer of Prolastin-C, the dominant augmentation therapy for Alpha-1 Antitrypsin Deficiency in the United States.
The Spanish company, as a concession to Italian competitor Kedrion, agreed to divest in a plant in New York, two centers in Alabama and North Carolina and the exclusive r
Read More »
05/18/11 DRIVE4COPD and the Country Music Association Set the Stage for the Next Voice of COPD Awareness!
Billy Ray Cyrus and Patty Loveless Select Tim Wright To Win
The Tune Up For COPD Songwriting Competition
Ridgefield, CT, May 18, 2011 – Landmark public health campaign DRIVE4COPD announced today that Tim Wright was chosen from more than 150 entries as the winner of the Tune Up for COPD Songwriting Competition. DRIVE4COPD Celebrity Ambassadors Billy Ray Cyrus and Patty Loveless were among the judges for the competition, launched in partnership with the Country Music Association (CMA)
Read More »
05/17/11 COPD Foundation, Borm Bruckmeier Publishing Develop Smoking Cessation Pocketcards for Physicians
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
COPD Foundation, Borm Bruckmeier Publishing Develop Smoking Cessation Pocketcards for Physicians
Washington, DC – May 16th, 2011 – The COPD Foundation has collaborated with Borm Bruckmeier Publishing to develop two new educational tools for physicians to use when diagnosing and treating their patients with Chronic Obstructive Pulmonary Disease (COPD). The new po
Read More »
05/17/11 Informa Healthcare, COPDF's COPD: Journal of Chronic Obstructive Pulmonary Disease Goes Digital
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
Informa Healthcare, COPD Foundation’s COPD: Journal of Chronic Obstructive Pulmonary Disease Goes Digital
NEW YORK – May 16, 2011 – COPD: Journal of Chronic Obstructive Pulmonary Disease – the first journal dedicated to publishing research on the impact of COPD – is launching a new media-rich digital format to accompany its standard electronic
Read More »
05/17/11 First National Biannual COPD Conference for Researchers, Healthcare Professionals Coming to the U.S.
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
First National Biannual COPD Conference for Researchers, Healthcare Professionals Coming to the U.S.
COPD Foundation Hosting Conference Series in Washington, DC Area
Washington, DC – May 16, 2011 – Originally hosted in Europe on even calendar years, the COPD Conference series for researchers and healthcare professionals is coming to the U.S. for the first tim
Read More »
05/17/11 U.S. COPD Coalition Assembling the Community for the Second National Conference on COPD
FOR IMMEDIATE RELEASE
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
U.S. COPD Coalition Assembling the Community for the Second National Conference on Chronic Obstructive Pulmonary Disease
December 2nd and 3rd, 2011
Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Crystal City, VA 22202
Washington, DC – May 17, 2011 – The U.S. COPD Coalition and its member organizations are hosting the Second National COPD Conferen
Read More »
04/21/11 COPD Foundation Hosts Spring Benefit May 12th, 2011
FOR IMMEDIATE RELEASE
COPD Foundation Hosts Spring Benefit May 12th, 2011
Washington, D.C. (April 21, 2011)—The COPD Foundation is hosting a spring benefit featuring a preview of the Our Lives, Our Air photography project and an intimate performance from country music artist, Patty Loveless, in effort to spread awareness of Chronic Obstructive Pulmonary Disease (COPD). The benefit will be on May 12th at the MacMillan Family’s Pool House (989 East Radcliffe Avenue, Cherry Hills
Read More »
04/20/11 2012 Accreditation and Certification Products Update To the National Committee for Quality Assurance
The COPD Foundation is a national not-for-profit organization solely dedicated to representing individuals with COPD in the United States. COPD, or Chronic Obstructive Pulmonary Disease, is an umbrella term used to describe progressive lung diseases, encompassing emphysema, chronic bronchitis, refractory asthma, and severe bronchiectasis. The COPD Foundation respectfully submits these comments in response to the above referenced proposed changes regarding the 2012 Accreditation and Certification
Read More »
04/18/11 COPD Foundation Receives Funding to Conduct COPD Education Efforts as Part of NHLBI Program
The National Heart Lung and Blood Institute's Learn More Breathe Better Campaign®
Continues to Expand Community Network
WASHINGTON, DC—(April 18, 2011)—The COPD Foundation was one of nine organizations to receive funding from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, to improve awareness and understanding of COPD. The award is part of the NHLBI’s COPD Learn More Breathe Better® campaign and will be grante
Read More »
04/13/11 April is "Donate Life" Month
Organ procurement organizations, transplant centers, national donation organizations and other organizations sponsor special awareness events and donor recognition ceremonies to promote donation awareness and registration. National Donate Life Month was established in 2003. Every day in April, people across the U.S. make a special effort to celebrate the tremendous generosity of those who have saved lives by becoming organ, tissue, marrow, and blood donors and to encourage more Americans to foll
Read More »
04/04/11 NHLBI Funds Nine Organizations to Improve Awareness of COPD
NHLBI's COPD Learn More Breathe Better campaign continues to expand community network
Nine state and local organizations will receive a total of $383,000 for chronic obstructive pulmonary disease (COPD) education initiatives, the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, announced today. The awards are part of the NHLBI’s COPD Learn More Breathe Better campaign and will be granted under the campaign's communications contract with
Read More »
03/29/11 RENOWNED ARTIST MICHAEL KALISH AND DRIVE4COPD PARTNER ON GROUND-BREAKING MONUMENT
Twenty Four Massive Pinwheels Made from License Plates Illustrate Vast Swath of American Lives Affected by COPD:
Ridgefield, CT, March, 29, 2011 – The DRIVE4COPD national public health initiative today announced its partnership with renowned American artist and sculptor Michael Kalish. Kalish will create a large-scale monument called 24M: The DRIVE4COPD Monument, inspired by the DRIVE4COPD campaign pinwheel icon. Kalish will use his signature medium, the license plate, to create 24 large-
Read More »
03/24/11 Statement From President John W. Walsh on FDA Pulmonary-Allergy Drugs Advisory Committee Meeting
On behalf of the COPD Foundation, a not-for-profit organization representing the millions of Americans affected by COPD, I am pleased to present comments and express our appreciation for your consideration of this NDA for indacaterol maleate—a once-a-day maintenance treatment for COPD.
This past December, the CDC announced that COPD is now been elevated to the third leading cause of death in the United States. There are 12 million Americans currently diagnosed with COPD but the National H
Read More »
03/15/11 Two National Organizations Join DRIVE4COPD Movement
U.S. COPD Coalition and COPD Alliance Bring Policy Focus and Expertise
Of More Than 320,000 Healthcare Professionals to Campaign
Ridgefield, CT, March 11, 2011 – Health initiative DRIVE4COPD today announced that two of the most powerful COPD organizations in America – the U.S. COPD Coalition and the COPD Alliance – have joined the mission to raise awareness of chronic obstructive pulmonary disease (COPD). With these additions, the country’s leading COPD groups are par
Read More »
03/11/11 Rep. Mike Ross Introduces Bill to Provide Coverage of Respiratory Therapists
FOR IMMEDIATE RELEASE
Contact:
Ifdy Perez, COPD Foundation
iperez@copdfoundation.org
Tel: 1-866-731-2673, ext. 398
March 11, 2011, Washington, DC – Congressman Mike Ross (D-AR) introduced HR 941, a bill that seeks to provide coverage of qualified respiratory therapists – performed under the general supervision of a physician – outside of a hospital-based setting for individuals covered under Medicare.
“Many people do not use their inhaled medicatio
Read More »
03/09/11 FDA Advisory Committee Recommends Approval of First Once-a-Day Long-acting Beta-agonist for COPD
FOR IMMEDIATE RELEASE
Contact:
Ifdy Perez, COPD Foundation
iperez@copdfoundation.org
Tel: 1-866-731-2673, ext. 398
FDA Advisory Committee Recommends Approval of First Once-a-Day Long-acting Beta-agonist for COPD:
Foundation applauds decision, commends support for new therapies to improve lives of patient community
March 9, 2011, Washington, DC – A Food and Drug Administration (FDA) advisory committee has voted 13-4 that Indacaterol Maleate - a 75 mcg once-daily novel lo
Read More »
03/09/11 RV4TheCause Taking Educational Programs On the Road to Spread COPD Awareness
March 9, 2011, Paramus, NJ – The COPD Foundation is partnering with RV4TheCause – a national charitable initiative designed to educate professional advisors on helping clients impacted by chronic illnesses -- on its second major professional seminar tour throughout Princeton, NJ, Washington, DC, Chapel Hill, NC, Jacksonville, FL and Tampa, FL, March 24, 2011 through April 10, 2011. A national Webinar will be broadcast March 31, 2011 at 1:30PM EST, hosted by Leimberg Information
Read More »
03/04/11 FDA Approves New Drug to Treat COPD
WASHINGTON DC- March 4, 2011- The U.S. Food and Drug Administration has approved roflumilast, a pill taken daily to decrease the frequency of exacerbations or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD).
“The COPD Foundation congratulates Forest Laboratories for the approval of roflumilast as an indication to treat COPD-related bronchitis,” says John W. Walsh, President and Co-Founder of the COPD Foundation. “We’re excited that thi
Read More »
03/04/11 COPD Foundation Names Official Journal
Contact:
COPD Foundation
Ifdy Perez
866-731-2673, ext. 398
iperez@copdfoundation.org
FOR IMMEDIATE RELEASE
NEW YORK – 2 March 2011 – COPD: Journal of Chronic Obstructive Pulmonary Disease – the first journal dedicated to publishing a range of research on the impact of COPD – has become the official journal of the COPD Foundation.
The mission of the COPD Foundation is to develop and support programs that improve quality of life for people whose lives ar
Read More »
03/03/11 FDA approves new drug to treat COPD
For Immediate Release
*Note: Daliresp has been approved as the trade name for roflumilast.
March 3, 2011 - The U.S. Food and Drug Administration approved roflumilast, a pill taken daily to decrease the frequency of flare-ups (exacerbations) or worsening of symptoms from severe chronic obstructive pulmonary disease (COPD).
Roflumilast, a new drug class for the treatment of COPD, is an inhibitor of an enzyme called phosphodiesterase type 4 (PDE-4). It is indicated for people with sev
Read More »
02/16/11 AARC Hosting Webcast February 18th, Discussing Upcoming Hill Day
The AARC will be hosting a webcast this Friday, February 18th at 2PM EST to discuss the upcoming Hill Day (March 7th-8th, 2011).
Miriam O'Day will be the presenter, and patients and consumers from both the Alpha-1 Association and the COPD Foundation are invited to join respiratory therapists on this Friday's call.
***To Access the Webcast***
To access the webcast room on Friday up to 60 minutes before the presentation begins, please use the following link: http://tinyurl.com/AARC-PACT-We
Read More »
02/09/11 National Patient Advocate Foundation Launches Comparative Effectiveness Research (CER) Database
New CER Database Catalogues Ongoing Research Studies Funded with $1.1 Billion Provided by American Recovery and Reinvestment Act (ARRA)
WASHINGTON, DC (February 9, 2011) – The National Patient Advocate Foundation (NPAF) has created a new Comparative Effectiveness Research (CER) Database available to the public on its website. The new database compiles comparative studies funded by the National Institutes of Health (NIH) and the Agency for Healthcare Research and Quality (AHRQ). The major
Read More »
02/08/11 COPD Shuttle Coming to Florida February 9th, COPD Awareness Day at the Capitol in Tallahassee, FL
Participants Will Go on Virtual Journey Inside Human Body to See the Damage of Smoking and Air Pollution on Lung Tissue
TALLAHASSEE, FL—February 8, 2011—The Florida COPD Awareness Day at the Capitol – February 9th, 400 South Monroe Street, Florida State Capitol Building Courtyard – hosted by the Florida COPD Coalition in conjunction with the COPD Foundation, will allow participants to ride the COPD Shuttle: Journey to the Center of the Lung, get
Read More »
01/25/11 Congressman Whitfield's Troubling Statements about Clean Air Act
The COPD Foundation would like to address concerning comments made by Congressman Ed Whitfield in an article in the National Journal. In the article, Whitfield attacked the Environmental Protection Agency’s (EPA) new climate regulations and the Clean Air Act, discussed revisions on policy that could have a detrimental impact on those living with COPD, and made troubling comments about COPD and the environment and clean air.
The COPD Foundation’s mission is to serve those diagn
Read More »
01/07/11 COPDers Invited To Take Survey by the Allergy & Asthma Network
The Impact of Asthma Survey, created by the Allergy & Asthma Network Mothers of Asthmatics, is looking for your input.
The survey is intended to provide information that will help win better treatment for everyone who has breathing problems.
When you fill out the survey, you can be sure that your challenges, questions and concerns will be heard and acted on. Just take a moment to fill it out, and send to friends or post on your Facebook page!
Click here to take the survey.
Read More »
01/05/11 Forest's COPD Candidate Delivers
Forest Laboratories, Inc. (NYSE: FRX - News) and Almirall recently announced positive top line data on their chronic obstructive pulmonary disease (COPD) candidate, aclidinium bromide. Results were presented from a pivotal phase III study (ATTAIN) that compared the safety and efficacy of aclidinium bromide (200μg and 400μg dosed twice daily) with placebo.
FRX - News) and Almirall recently announced positive top line data on their chronic obstructive pulmonary disease (COPD) candidate, a
Read More »
01/04/11 CMS EXPANDS HEALTHCARE PROVIDER DIRECTORY, LAUNCHES FIRST PHASE OF PHYSICIAN COMPARE WEB SITE
More Information For Consumers Including Data About Quality of Care
Today, the Centers for Medicare & Medicaid Services (CMS) enhanced the Physician Directory tool at www.medicare.gov with new information about physicians and other healthcare workers in their communities and the services those professionals provide.
The new feature, called Physician Compare, expands and updates CMS’ Healthcare Provider Directory, which has helped millions of beneficiaries find Medicare-part
Read More »
01/04/11 Albuterol Recalled
ISSUE: The Ritedose Corporation is conducting a voluntary recall of 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25, 30, and 60 unit dose vials. This product is being recalled because the 2.5 mg/3 mL single use vials are embossed with the wrong concentration of 0.5 mg/ 3 mL and therefore, represents a potential significant health hazard. Only the unit dose vials are incorrectly embossed as containing 0.5 mg/3 mL. The correct concentration of 2.5 mg/3 mL is labeled on the primary foil ov
Read More »
01/04/11 CMS Expands Healthcare Provider Directory Launches First Phase Of Physician Compare Web Site
More Information For Consumers Including Data About Quality of Care
Today, the Centers for Medicare & Medicaid Services (CMS) enhanced the Physician Directory tool at www.medicare.gov with new information about physicians and other healthcare workers in their communities and the services those professionals provide.
The new feature, called Physician Compare, expands and updates CMS’ Healthcare Provider Directory, which has helped millions of beneficiaries find Medicare-part
Read More »
12/10/10 New CDC Report Puts COPD in #3 Spot in Mortality Rates
Contact:
COPD Foundation
Ifdy Perez; 1-866-731-2673, ext. 398
iperez@copdfoundation.org
FOR IMMEDIATE RELEASE
COPD Ranked Third Leading Cause of Death in the U.S., CDC Reports
Previously projected to reach this level in 2020, COPD advances twelve years sooner
WASHINGTON, D.C. December 9, 2010 — The Centers for Disease Control (CDC) and Prevention’s National Center for Health Statistics (NCHS) released a report today, “Deaths: Pr
Read More »
11/30/10 Foundation Hosting Annual Awards & Recognition Benefit in NYC to Honor Community Leaders
FOR IMMEDIATE RELEASE
Contact: Ifdy Perez, COPD Foundation
iperez@copdfoundation.org
1-866-731-2673, ext. 398
COPD Foundation Hosts Annual Awards and Recognition Benefit in New York City to Honor Community Leaders
U.S. Senator Michael Crapo, Dr. James Kiley of the National Heart, Lung and Blood Institute, Dr. Gerard Turino of St. Luke’s-Roosevelt Hospital, Shell Foundation and DRIVE4COPD Campaign among others are recognized for their efforts in research, awareness,
Read More »
11/30/10 Shuttle Coming to Las Vegas for AARC Conference, December 6-8
Contact:
COPD Foundation
Ifdy Perez; 1-866-731-2673, ext. 398
iperez@copdfoundation.org
FOR IMMEDIATE RELEASE
American Association for Respiratory Care Hosts COPD Shuttle: Virtual Journey Inside Human Body Reveals Ravages of Smoking and Air Pollution on Lung Tissue
AARC International Respiratory Congress; December 6-8, 2010
Las Vegas Convention Center
WASHINGTON, D.C. — November 30, 2010 — Using a 20-seat state-of-the-art mobile motion simulator called
Read More »
11/17/10 COPDF Announces Launch of COPD Biomarkers Qualification Consortium
Patient and research communities welcome new government, academic and pharmaceutical collaborative
Washington, D.C. (November 17, 2010) — The COPD Foundation announces the launch of an unprecedented collaborative effort to pool information on Chronic Obstructive Pulmonary Disease (COPD): the COPD Biomarkers Qualification Consortium (CBQC). The CBQC brings together government agencies, academic institutions and pharmaceutical companies that will share research data on COPD biomarkers&mda
Read More »
11/17/10 Experts Call for National Strategies to Tackle COPD - An Emerging Epidemic in the Workforce
New report highlights devastating impact of Chronic Obstructive Pulmonary Disease (COPD) in people of working age. Nearly 1 in 5 45-68 year olds with COPD surveyed were forced to retire prematurely.
LONDON, UK - November 17, 2010 – COPD Uncovered 2010, a new report issued today, exposes the devastating economic, social and personal impact of COPD in the 40–65 years age group – the mainstay of the global workforce1,2. These results have led respiratory experts to call for th
Read More »
11/16/10 Pulmonary Health: "Declaration of War on COPD" Insert in Tomorrow's New York Daily News
Pulmonary Health is a supplement distributed by MediaPlanet in the New York Daily News, covering all aspects of COPD.
Click here to read the full PDF.
Read More »
11/10/10 COPD Foundation Lauds Addition of Prevalence Question to 2011 BRFSS
FOR IMMEDIATE RELEASE
Contact: Ifdy Perez, COPD Foundation
iperez@copdfoundation.org
1-866-731-2673, ext. 398
Chronic Obstructive Pulmonary Disease (COPD) Foundation Lauds Addition of Prevalence Question to 2011 State-Based Survey System Released by Centers for Disease Control and Prevention
Washington, DC -- November 9, 2010 -- Determining the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in every State is becoming a reality, thanks to the 2011 Behavioral Risk Factor
Read More »
11/09/10 Patient Groups Back Bill Supporting US Veterans with COPD
FOR IMMEDIATE RELEASE
Contact:
Ifdy Perez, COPD Foundation
Email: iperez@copdfoundation.org
Tel: 1-866-731-2673, ext. 398
November is National COPD Awareness Month
Veterans Day is November 11
Patient Groups Back Bill Supporting US Veterans with COPD
Legislation directs Department of Veterans Affairs to improve prevention, diagnosis, and treatment of COPD, 4th leading cause of death in US
Washington, D.C. (November 9, 2010)--The COPD Foundation, along with the Americ
Read More »
11/08/10 Contract suppliers selected under new Medicare program
The Centers for Medicare & Medicaid Services (CMS) released on Wednesday, November 3rd, the list of the 356 suppliers that have contracts with Medicare to provide certain medical equipment and supplies to beneficiaries in nine communities across the U.S. at competitive bid rates. This new program, authorized by Congress, is expected to save Medicare and its beneficiaries nearly $28 billion over 10 years.
"The Medicare beneficiaries in the first ten competitive bidding markets have
Read More »
11/08/10 Foundation Hosts Southeast Regional Summit to Identify Strategies for Overcoming the Burdens of COPD
ATLANTA, GA—November 2, 2010—Representatives from professional organizations, government agencies, patient advocacy groups, and managed care providers along with people living with Chronic Obstructive Pulmonary Disease (COPD) will convene at the Southeast Regional COPD Summit to collaborate on ways to tackle the growing burden of COPD in local communities. The Summit will be held on Monday, November 15 at the Atlanta Airport Marriott starting at 8AM, Free registration is available at
Read More »
11/04/10 New York COPD Coalition Releases Action Plan to Combat COPD in New York
The New York COPD Coalition today released the New York COPD Action Plan in response to the growing burden of Chronic Obstructive Pulmonary Disease (COPD) and the inadequate attention the disease has received to date. COPD refers to the group of diseases, including emphysema and chronic bronchitis, which cause airflow blockage and destruction of the air sacs triggering breathing-related problems. The Action Plan is a blueprint for identifying the many undiagnosed COPD patients in New York
Read More »
11/04/10 DRIVE4COPD "GREAT AMERICAN SCREEN OFF" SEEKS TO FIND MILLIONS OF AMERICANS AT RISK FOR COPD
Unprecedented Collaboration of Celebrities, Sports, Healthcare and
Consumer Organizations Unite to Put the Brakes on COPD
Ridgefield, CT, November 4, 2010 – Events across the country today mark the first annual DRIVE4COPD
Great American Screen Off to raise awareness of chronic obstructive pulmonary disease (COPD) and screen people for their risk of the disease. The Screen Off is believed to be the largest single day in our nation’s history dedicated to screening for and raisin
Read More »
10/21/10 Learning to Live Healthy with Chronic Obstructive Pulmonary Disease: USCC Hosts Webinar
FOR IMMEDIATE RELEASE
WASHINGTON, D.C. (October 21, 2010)—Individuals, their family members and caregivers nationwide will have the opportunity to join the thousands that have already registered to learn effective ways to live healthy with their COPD diagnosis by participating in the U.S. COPD Coalition’s free Webinar, Wednesday, October 27, 2010, 4PM-5PM Eastern Time. Register for the Webinar at: http://bit.ly/COPD_Webinar_Healthy_1.
“Once again, the members of the
Read More »
10/20/10 COPD SHUTTLE COMING TO JOHNS HOPKINS BAYVIEW MEDICAL CENTER
Participants Will go on Virtual Journey Inside Human Body to See the Damage of Smoking and Air Pollution on Lung Tissue
Free Event on Oct. 26 is Open to the Public
Baltimore, Md.—Using a 20-seat state-of-the-art mobile motion simulator called COPD (Chronic Obstructive Pulmonary Disease) Shuttle: Journey to the Center of the Lung, the COPD Foundation harnesses the power of immersive innovation to take riders on a five-minute microscopic journey into the human body and witness the dev
Read More »
10/18/10 COPD Shuttle: Journey to the Center of the Lung at the USA Science and Engineering Festival
Virtual Journey Inside Human Body Reveals Ravages of Smoking and Air Pollution on Lung Tissue: COPD Foundation Unveils Motion Simulator Capsule
USA Science and Engineering Festival, October 23-24, 2010, Washington, D.C.
WASHINGTON, D.C. (October 18, 2010)—Using a 20-seat state-of-the-art mobile motion simulator called COPD Shuttle: Journey to the Center of the Lung, the COPD Foundation harnesses the power of immersive innovation to take riders on a five-minute microscopic jour
Read More »